(Q93515830)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2527092%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

title

Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2527092%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

author name string

A Hamik

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2527092%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

S J Peroutka

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2527092%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2527092%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

7 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2527092%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2527092%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2527092%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

page(s)

307-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2527092%20AND%20SRC:MED&resulttype=core&format=json

Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol

7 May 2020

cites work

1 reference

12 December 2020

PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST

1 reference

12 December 2020

The control of chemotherapy-induced emesis

1 reference

12 December 2020

Metoclopramide-induced Parkinsonism. Clinical characteristics of ten cases

1 reference

12 December 2020

Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy

1 reference

12 December 2020

MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.

1 reference

12 December 2020

Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms

1 reference

12 December 2020

Evidence for an extra-abdominal site of action for the 5-HT3 receptor antagonist BRL24924 in the inhibition of radiation-evoked emesis in the ferret

1 reference

12 December 2020

5-Hydroxytryptamine M-receptor antagonism in the hypothalamus facilitates gastric emptying in the guinea-pig

1 reference

12 December 2020

The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis

1 reference

12 December 2020

The efficacy of GR38032F, an antagonist of 5-hydroxytryptamine-3 (5-HT3) in the prophylaxis of cisplatin (CDDP)-induced nausea and vomiting

1 reference

12 December 2020

Emesis as a Critical Problem in Chemotherapy

1 reference

12 December 2020

Metoclopramide. An updated review of its pharmacological properties and clinical use.

1 reference

12 December 2020

Antiemetic properties of the 5HT3-receptor antagonist, GR38032F

1 reference

12 December 2020

Drug therapy. Metoclopramide

1 reference

12 December 2020

Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis

1 reference

12 December 2020

Neuropharmacology of emesis induced by anti-cancer therapy.

1 reference

12 December 2020

Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism

1 reference

12 December 2020

The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin

1 reference

12 December 2020

Dystonia with Droperidol Therapy

1 reference

12 December 2020

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

1 reference

12 December 2020

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

12 December 2020

[3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes.

1 reference

12 December 2020

Optimum management of nausea and vomiting in cancer chemotherapy

1 reference

12 December 2020

Prolonged metoclopramide-induced dyskinetic reaction

1 reference

12 December 2020

5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis

1 reference

12 December 2020

Antiemetics: neurotransmitter receptor binding predicts therapeutic actions

1 reference

12 December 2020

Neurotransmitter receptor binding studies predict antiemetic efficacy and side effects.

1 reference

12 December 2020

First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00304763

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2527092%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

1 reference